Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

R Dziadziuszko, A. Ardizzoni, P.E. Postmus, E.F. Smit, A Price, C. Debruyne, C Legrand, G. Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1271-6
JournalEuropean Journal of Cancer
Volume39
Issue number9
DOIs
Publication statusPublished - 2003

Cite this